MedTrace Logo

Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors

NCT07522593 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Baduanjin exercise could be adopted by breast cancer survivors and improve their upper limb dysfunction. The main questions it aims to answer are:

* Does Baduanjin exercise improve upper limb dysfunction among breast cancer survivors?
* What problems or adverse events do participants have if they adopt Baduanjin exercise to improve upper limb dysfunction?

Participants will:

* Adopt Baduanjin exercise following an evidence-based intervention protocol
* Report their exercise frequency, length, and unexpected symptoms
* Receive three times assessment and follow-up every week

Conditions

  • Breast Cancer Survivor

Interventions

BEHAVIORAL

Baduanjin exercise

Baduanjin exercise is a low-to-moderate-intensity aerobic mind-body exercise that integrates movement (physical postures), meditation (focused attention), and controlled breathing. When practicing it, people stand in a position and perform eight movements, including 1) Two Hands Hold up the Heavens; 2) drawing the bow to shoot the eagle; 3)separate heaven and earth, 4)wise owl gazes backward or looking back, 5)sway the head and shake the tail, 6)two hands hold the keen to strengthen the kidneys and waist, 7) clench the fists and glare fiercely; 8) bouncing on the toes seven times.

Sponsors & Collaborators

  • University of Southern Queensland

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2026-12-31
Completion
2027-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07522593 on ClinicalTrials.gov